Statistics
Total Visits
| Name | Views |
|---|---|
| MS-275 (ENTINOSTAT) PROMOTES SUSTAINED TUMOR REGRESSION IN THE CONTEXT OF BOOSTING ONCOLYTIC IMMUNOTHERAPY | 677 |
Total Visits per Month
| Name | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 |
|---|---|---|---|---|---|---|---|
| MS-275 (ENTINOSTAT) PROMOTES SUSTAINED TUMOR REGRESSION IN THE CONTEXT OF BOOSTING ONCOLYTIC IMMUNOTHERAPY | 7 | 9 | 9 | 20 | 11 | 17 | 2 |
File Downloads
| Name | Views |
|---|---|
| fulltext.pdf | 665 |
Top Country Views
| Name | Views |
|---|---|
| Canada | 211 |
| United States | 66 |
| China | 15 |
| Japan | 11 |
| Australia | 7 |
| Germany | 7 |
| Belgium | 2 |
| Brazil | 2 |
| United Kingdom | 2 |
| Iran | 2 |
Top City Views
| Name | Views |
|---|---|
| Hamilton | 198 |
| Tokyo | 10 |
| San Mateo | 9 |
| Menlo Park | 8 |
| Beijing | 6 |
| Lanark | 6 |
| Fairfield | 4 |
| San Ramon | 4 |
| Des Moines | 3 |
| Zhengzhou | 3 |
